Zhitong Tech Secures Nearly RMB 100 Million Series A Funding to Advance Exoscopic Solutions for Microsurgery

December 16th, news came that recently, Jiaxing AINNOVI Technology Co., Ltd. (referred to as "AINNOVI") announced the completion of nearly RMB100 million in Series A financing. This round of financing was jointly led by Aier QingShi Fund and Shanghai Sunland Investment Management Co., Ltd., with participation from LINGYI CAPITAL, Chongqing Airuilin. The proceeds of this financing will be mainly used for the research and development, registration, and market promotion of modular products for surgery and ophthalmology, as well as the whole machine of microscopic surgical endoscopes.

AINNOVI was founded in 2020, with a strong R&D team dedicated to the research and development of key technologies in visual perception and intelligent decision-making for microsurgical scenarios. Focusing on ultra-high-definition stereoscopic vision technology and intelligent human-computer interaction technology as the core product line direction, the company has established a strategic development plan of "computational imaging + industry application." It aims to become a leader in precision visual imaging technology and a global provider of high-end medical imaging modules, equipment, and digital surgical solutions.